肝细胞癌中的巨分化:关于瘤进展和转移的lncRNA中心观点
Ahmad Ghorbani Vanan1,2, Mohammad Taha Nami3, Farid Ghorbaninezhad1,2
1Student Research Committee, Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Clinical and experimental medicine
|May 25, 2025
概括
像HULC和MALAT1这样的长非编码RNA (lncRNAs) 通过促进前瘤巨细胞极化来驱动肝细胞癌 (HCC) 的进展. 准这些lncRNAs为HCC治疗提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 肝细胞癌 (HCC) 是一种与慢性炎症和免疫细胞活性相关的侵袭性癌症.
- 长非编码RNAs (lncRNAs) 是HCC病变发生的关键调节者,作为瘤基因或瘤抑制剂.
- 大细胞两极分化显著影响HCC瘤进展和瘤微环境.
研究的目的:
- 研究 lncRNAs 在 HCC 中的作用.
- 阐明特定的lncRNAs (HULC,MALAT1) 如何调节HCC瘤微环境中的巨细胞极化.
- 探索 lncRNAs 在 HCC 诊断,预后和治疗中的临床影响.
主要方法:
- 对lncRNA参与HCC病变的分析.
- 研究HULC和MALAT1影响巨细胞极化的分子机制.
- 评估lncRNA与表观遗传修饰剂 (例如EZH2) 的相互作用及其对基因表达的影响.
- 评估由lncRNAs调节的细胞因子概况和免疫调节剂 (IL-10,TGF-β).
- 探索临床应用,包括诊断,预后和治疗.
主要成果:
- 关键的lncRNAs (HULC,MALAT1) 被确定为HCC中巨分极的调节者.
- 这些lncRNAs通过调节细胞因子 (IL-10,TGF-β) 来引导巨细胞向M2类,前瘤表型.
- lncRNAs与EZH2相互作用,改变基因素修饰和染色质可访问性,以加强免疫抑制.
- lncRNA稳定了编码炎症媒介的mRNA,促进了免疫抑制性瘤微环境.
结论:
- lncRNAs通过影响巨细胞两极分化和免疫逃避,在HCC进展中发挥关键作用.
- 在HCC中,HULC和MALAT1是免疫抑制瘤微环境的显著调解者.
- lncRNAs具有潜力作为最小侵入性的诊断标记物,预后生物标记物和HCC的治疗点.
- 向lncRNAs可能会破坏促进瘤炎症并恢复抗瘤免疫力,从而改善HCC患者的治疗结果.
相关概念视频
lncRNA - Long Non-coding RNAs
9.8K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.8K
Metastasis
6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K


